Systemic but not mucosal immunity induced by AVA prevents inhalational anthrax
- 31 October 2007
- journal article
- Published by Elsevier BV in Microbes and Infection
- Vol. 9 (12-13), 1478-1483
- https://doi.org/10.1016/j.micinf.2007.08.002
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Complement Depletion Renders C57BL/6 Mice Sensitive to the Bacillus anthracis Sterne StrainInfection and Immunity, 2005
- CpG Oligodeoxynucleotides Adsorbed onto Polylactide-Co-Glycolide Microparticles Improve the Immunogenicity and Protective Activity of the Licensed Anthrax VaccineInfection and Immunity, 2005
- Nasal immunization of mice with a rotavirus DNA vaccine that induces protective intestinal IgA antibodiesVaccine, 2004
- Cytokine Response to Infection with Bacillus anthracis SporesInfection and Immunity, 2004
- CpG oligonucleotides improve the protective immune response induced by the anthrax vaccination of rhesus macaquesVaccine, 2004
- Adherence to Antimicrobial Inhalational Anthrax Prophylaxis among Postal Workers, Washington, D.C., 2001Emerging Infectious Diseases, 2002
- CpG DNA overcomes hyporesponsiveness to hepatitis B vaccine in orangutansVaccine, 2000
- AnthraxThe New England Journal of Medicine, 1999
- CpG motifs in bacterial DNA trigger direct B-cell activationNature, 1995
- Comparative safety and efficacy against Bacillus anthracis of protective antigen and live vaccines in miceMicrobial Pathogenesis, 1988